1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. GYRE THERAPEUTICS INC
Gyre Therapeutics Inc XNAS: GYRE

Gyre Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Expensive Performer
about

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-sta...

Read More
8.16 0.45 (5.84%)
35.34% Fall from 52W High
156.5K
XNAS Volume

XNAS 09 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Gyre Therapeutics Inc is on 17 Mar 2026 for the purpose of Gyre Therapeutics Inc Fourth Quarter Earnings Results for 2025 See details
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Expensive Valuation
29.7 / 100
Momentum Score
Technically Neutral
57.1 / 100
Expensive Performer These stocks have medium quality and momentum.Their expensive valuations suggest caution View Similar Embed DVM
Analyst Price Target
19
1Yr Price target upside is 129%
3 analysts

10

S

7

W

5

O

1

T

SWOT Analysis

Gyre Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..